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Abstract
Children hospitalized in Neonatal Intensive Care Units (NICU) present an increased risk for Sensorineural Hearing 
Loss (SNHL) due to prematurity, hypoxia-ischemia, hyperventilation, low birth weight and the use of ototoxic drugs. 
The aim of this study was to assess the prevalence of SNHL in newborns hospitalized in a NICU using Transient 
Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Responses (A-ABR) and analyze the 
associated risk factors. A sample of 153 newborns hospitalized in NICU underwent TEOAE, A-ABR and clinical ABR to 
evaluate the presence of hearing deficits. Prevalence of SNHL was calculated and odds ratio for specific risk factors 
was measured. One-hundred fifteen babies (86.7%) presented normal hearing at TEOAE and A-ABR. Fifteen children 
had a REFER response at TEOAE and a PASS response at A-ABR. Twenty-five children (16.3%) had a REFER A-ABR 
and were addressed to clinical ABR. A diagnosis of SNHL was made in 12 (7.8%) newborns. An increased risk of 
SNHL was observed in preterm children <28 weeks (p=0.0135), in children with neurological disorders (p=0.02), that 
underwent surgery (p=0.0002), affected from premature retinopathy (p=0.0006), craniofacial malformation (p=0.007) 
and that had sepsis (p=0.04). Additional risk factors for SNHL in our sample were a maternal disease during pregnancy 
(p=0.0011), cesarean delivery (p<0.0001) and a twin pregnancy (p<0.0001). SNHL in newborns is correlated with 
hospitalization in NICU. An accurate hearing screening associated to a rigorous clinical medical collection of data is 
necessary to promptly identify cases of SNHL in children with a special attention to those hospitalized in NICU and plan 
proper intervention. 
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INTRODUCTION
Sensorineural Hearing Loss (SNHL) in newborns 
represents a common condition with serious effects on 
the ability to develop speech, language and social skills1-3. 
The prevalence of SNHL ranges from 1 to 3 per thousand 
newborns4-13. Universal newborn hearing screening 
programs are available in most industrialized countries 
and help early identification, diagnosis and intervention 
in infants with hearing loss4-11. Admission to a Neonatal 
Intensive Care Units (NICU) is considered a risk factor 
for SNHL, as documented by the Joint Committee on 
Infant Hearing (JCIH)14, due to many conditions including 
prematurity, hypoxia-ischemia, hyperventilation, low birth 
weight and the use of ototoxic drugs15-22. Prevalence 
of SNHL in children admitted in NICU is nearly 4%23,24. 
The aim of this study was to assess the prevalence of 
SNHL in new born admitted to a NICU using Transient 
Evoked Otoacoustic Emissions (TEOAE) and Automated 
Auditory Brainstem Responses (A-ABR) and analyses the 
associated risk factors.
MATERIALS AND METHODS
This prospective study was conducted in a University 
hospital between March and November 2017. All newborns 
admitted to the NICU of our hospital were included in 
the study. The study was approved by the institutional 
review board of the hospital without release of a referee 
number. The study was performed in accordance with the 
Declaration of Helsinki for human rights. All parents of the 
newborns included in the study signed a written consent 
authorizing the inclusion.
Collection of data from medical records and 
clinical observation
The following data were collected for each subject: 
sex, age (in months), prematurity, family history for 
genetic SNHL, presence of chromosomal disorders, 
consanguinity between parents, maternal infections, 
Apgar score at 1’<5 or/and at 5’<7, use of mechanical 
ventilation for more than 5 days, presence of meconium 
aspiration syndrome, neurologic disorders, cerebral 
complications, hyperbilirubinemia and necessity of 
phototherapy or exchange transfusion, low birth weight, 
surgery, presence of Retinopathy of Prematurity (ROP), 
craniofacial malformations, sepsis, use of antibiotics 
included the known ototoxic, maternal diseases during 
pregnancy, maternal use of medicines during pregnancy, 
assisted conception, caesarean section, twin pregnancy 
(Table 1). The risks were classified by their prevalence as 
common when they affected >50% of the children, less 
common if <50%, rare if < 10% and extremely rare when 
the condition was present in <2% of the children.
Collection of audiological data
Two expert audiology technicians recorded TEOAE 
and A-ABR in all children hospitalized in the NICU of 
our hospital. The results of the tests were analysed by 
a physician with more than 20 years of experience in 
audiology.
TEAOE test was executed placing the earplugs in both 
ears, one ear at a time, during sleep or at the end of 
feeding. TEOAE were recorded in both ears by using 
Eroscan Screener OAE Maico Diagnostic and the results 
were documented as either PASS or REFER. TEOAE 
were recorded with a non-linear click-sequence stimulus 
at intensity of 70 dB SPL level (45 dB HL), with a click rate 
of approximately 60 Hz and a frequency range between 
1.4 and 4.5 kHz. A-ABR was performed using Integrity 
V500 equipment. The test required less than 2 minutes for 
its execution. Electrodes were placed on the newborn’s 
forehead, nape and shoulder for detecting the responses 
from the auditory brainstem. The screening was done 
in a quiet room during sleep; evaluation was based on 
noise-weighted averaging and sample masking using a 
click stimulus of 40 dB nHL. The clicks were delivered by 
ER-3C insert earphones. The electrophysiological signals 
were amplified and analyzed. Children with a unilateral 
or bilateral REFER response in A-ABR were further 
investigated using clinical ABR to confirm the presence 
or the absence of SNHL before six months of age. ABR 
signals were recorded with Eclipse (Interacustics) in 
clinical, automatic modality using a decreasing (100 dB 
to 10 dB) single click stimulus. Contralateral masking 
was applied if asymmetric responses were observed23-25. 
After cleaning skin with abrasive paste, silver plated 
surface electrodes were applied in conventional positions 
using adhesive tape (black-left or right earlobe, red-Fz, 
green-breastbone). In accordance to actual ABR criteria, 
we analysed the absolute latency of waves I, III, and V, 
interpeak latencies (I-III, III-V, I-V), interaural difference of 
interpeak I-V. ABR was considered within normal range if 
a wave V could be found with at least two repetitions at 
60 dB SPL (35 dB nHL) with normal latency and interpeak 
values for patient's age. We also investigated the presence 
Maternal infections
Cytomegalovirus, Toxoplasma, Rubeola, Candida albicans, E.coli, Chlamydia, Syphilis, Mycoplasma and 
Hepatite C virus
Maternal diseases hypothyroidism, pre-eclampsia, hypertension, gestational diabetes
Cerebral complications
brain hemorrage, Germinal Matrix Hemorrhage (GMH), cerebellar hypoplasia, stroke, hydrocephalus, 
oloprosocephalia, cerebral hematom and alteration of lateral ventriculi
Antibiotics
amphotericine, metramidazol, clarytromicine, amoxycilline, tobramicine, ampycilline, netilmicin, vancomicine, 
meropenem, amikacine, genatmicine, piperacilline, benzilpenicelline, teicoplanine, ceftaxidime
Chromosomic mutations trisomy 13, microcephaly, polydactilia
Surgery plastic, ocular, abdominal, cardiologic surgeries and tracheostomy
Table 1. Risk factors evaluated in our sample.
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was calculated for each risk factor. P was considered as 
significant <0.05.
RESULTS
Hearing function
Our sample included 153 children, 84 males and 69 
females, with an average gestational age of 33 weeks 
(23-42 weeks). One-hundred thirteen babies (73.9%) 
presented normal hearing at TEOAE and A-ABR. Fifteen 
children (9.8%) had a REFER response at TEOAE and a 
PASS response at A-ABR. Twenty-five children (16.3%) 
had a REFER A-ABR response and were addressed to 
clinical ABR evaluation (Figure 1). All children with altered 
A-ABR results underwent clinical ABR. The results of 
clinical ABR showed that 12/25 (48%) children had a 
moderate (41 to 55 dB HL) and profound (>91 dB HL) 
SNHL; 11/25 (44%) were false positives and had a normal 
hearing. Among children with hearing loss, four (33.4%) 
had a unilateral profound SNHL, three (25%) a bilateral 
profound SNHL, three (25%) a unilateral moderate SNHL, 
one (8.3%) a bilateral moderate SNHL and one (8.3%) 
received a diagnosis of auditory neuropathy (Figure 2). 
Two children were lost during follow up.
Risk factors
Conditions observed in our sample are detailed in Table 
2. Prematurity was observed in 84.9% (130 children) of 
patients hospitalized in the NICU; 87 children (56.9%) 
stayed in NICU more than 5 days. None of the children 
of conductive hearing loss in all patients; conductive 
hearing loss was diagnosed with a positive otoscopy for 
middle ear disorders, a type B or C tympanogram with 
absent acoustic reflexes, and increased values of waves 
I, III and V absolute latency with normal I-III, III-V and I-V 
interpeaks.
Statistical analysis
The prevalence of hearing loss was calculated. Odds ratio 
Figure 1. Results of Transient Evoked Otoacoustic Emissions 
(TEOAE) and Automated Auditory Brainstem Responses (A-ABR) 
tests.
Risk Factor SNHL (N=12)
False Positives 
(N=11)
Normal 
Hearing(N=130)
Prematurity 12 (28 weeks) 11 (31 weeks) 107 (32 weeks)
Hospitalization in Neonatal Intensive Care Unit (NICU) over 5 days 10 7 70
Family anamnesis of genetic sensorineural hearing loss 0 0 0
Chromosomal disorders 2 1 5
Consanguinity 0 0 1
Maternal infections 2 3 14
Apgar score at 1’ < 5 or/and at 5’ < 7 1 1 12
Mechanical ventilation for more than 5 days 7 4 41
Meconium aspiration syndrome 0 0 0
Neurologic disorders 1 0 0
Cerebral complications 1 2 19
Hyperbilirubinemia 0 0 2
Low birth weight 12 (1015 gr) 10 (1655 gr) 95 (1682 gr)
Surgery 6 0 0
Presence of retinopathy of prematurity 6 2 12
Craniofacial malformations 2 0 0
Sepsis 3 2 8
Use of antibiotics 10 6 82
Use of ototoxic antibiotics 10 6 79
Maternal diseases during pregnancy 4 3 3
Maternal use of medicines during pregnancy 2 0 0
Assisted procreation 1 1 1
Caesarean childbirth 8 6 6
Twin pregnancy 4 4 4
Table 2. Conditions observed in our sample sorted by children with Sensorineural Hearing Loss (SNHL), false positives and children 
with normal hearing.
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had a positive history for genetic SNHL and meconium 
aspiration syndrome.
In children with a clinical diagnosis of SNHL (n=12), 
prematurity (<28 weeks) and low weight at birth were 
common findings in all subjects (n=12, 100%), followed by 
hospitalization in NICU for more than 5 days (n=10, 83.3%), 
the use of ototoxic antibiotics (n=10, 83.3%), caesarian 
childbirth (n=8, 66.6%), mechanical ventilation over 5 days 
(n=7, 58.3%), retinopathy of prematurity (ROP) (n=6, 50%) 
and surgery (n=6, 50%). Less-common findings were twin 
pregnancy (n=4, 33.3%) and maternal disease during 
the pregnancy (n=4, 33.3%) followed by sepsis (n=3, 
25%), maternal infections (n=2, 16.7%), chromosomal 
disorders (n=2, 16.7%), craniofacial malformations (n=2, 
16.7%) and maternal use of medicines during pregnancy 
(n=2, 16.7%). Rare findings were low Apgar score (n=1, 
8.3%), neurological disorders (n=1, 8.3%), cerebral 
complication (n=1, 8.3%) and assisted procreation 
(n=1, 8.3%). In this group, we did not observe any case 
of consanguinity and hyperbilirubinemia. In children with 
normal hearing function (n=141), prematurity (>31 weeks) 
was the most common finding (n=118, 83.7%) followed 
by low weight at birth (n=105, 74.4%), use of ototoxic 
antibiotics (n=85, 60.3%) and hospitalization in NICU more 
than 5 days (n=77, 54.6%). Less common observations 
were mechanical ventilation over 5 days (n=45, 31.9%), 
cerebral complications (n=21, 14.9%), maternal infections 
(n=17, 12%). Rare findings were ROP (n=14, 9.9%), low 
Apgar score (n=13, 9.2%), caesarean childbirth (n=12, 
8.5%), sepsis (n=10, 7%), twin pregnancy (n=8, 5.6%), 
chromosomal disorders (n=6, 4.2%) and maternal disease 
during the pregnancy (n=6, 4.2%). Very rare findings 
included hyperbilirubinemia and necessity of phototherapy 
or exchange transfusion (n=2, 1.4%), assisted procreation 
(n=2, 1.4%) and consanguinity (n=1, 0.7%). In this group, 
we did not observe any case of surgery, maternal use of 
medicines during pregnancy, and neurological disorders 
(Table 3). 
Odds ratio for each specific finding
We identified an increased risk of developing SNHL for 
nine of the twenty risk factors included in the analysis. 
In particular, SNHL was statistically associated with: 
prematurity <28 weeks (odds ratio: 35.9677; CI 95%: 
2.0981 to 616.5861; p=0.0135 ), neurological disorders 
(odds ratio: 36.9130; CI 95%: 1.4219-958.3075; p= 
0.02), surgery (odds ratio: 283.0000; CI 95%: 14.3455-
5582.8589; p=0.0002), ROP (odds ratio: 9.0714; CI 95%: 
2.5756-32.9499; p=0.0006), craniofacial malformation 
(odds ratio: 67.3810; CI 95%:3.0341-1496.4081; p=0.007), 
sepsis (odds ratio:4.3667; CI 95%: 1.0178-18.7336; 
p=0.04), maternal disease during pregnancy (odds ratio: 
11.2500; CI 95%: 2.6327-48.0729; p=0.0011), caesarean 
childbirth (odds ratio: 21.5000; CI 95%: 5.6404-81.9536; 
p<0.0001) and twin pregnancy (odds ratio: 33.2500; 
CI 95%: 8.2297-134.3389; p<0.0001). The other eleven 
risk factors did not show odds ratio with a statistically 
significant value. The odds ratio of these risk factors were: 
hospitalization in NICU over 5 days (odds ratio: 4.1558; CI 
95%: 0.8786-19.6584; p=0.07), chromosomic disorders 
(odds ratio: 4.5000; CI 95%:0.8022-25.2421; p=0.08), 
maternal infections (odds ratio: 1.4588; CI 95%: 0.2944-
7.2299; p=0.6), Apgar score (odds ratio: 0.8951; CI 95%: 
0.1069-7.4959; p=0.9), mechanical ventilation (odds 
ratio: 2.9867; CI 95%:0.8986-9.9264; p=0.07), cerebral 
 
Figure 2. Degree of sensorineural hearing loss (SNHL) found in our sample.
Antibiotic SNHL (N=12) Normal Hearing (n=141)
Ampicilline 83.30% 73.80%
Netilmicine 83.30% 72.70%
Meropenem 41.60% 11.40%
Tobramicine 25% 10.20%
Claritromicine 25% 13.60%
Metromidazole 8.30% 2.20%
Anfotericine 8.30% 1%
Vancomicine 50% 20.40%
Teicoplanine 8.30% 2.20%
Amikacine 8.30% 3.40%
Gentamicine 8.30% 2.20%
Piperacilime 0% 0%
Ceftazidime 0% 2.20%
Amoxicilline 0% 13.60%
Benzipenicelline 0% 1.10%
Table 3. Antibiotic treatment in children with Sensorineural 
Hearing Loss (SNHL) and with normal hearing.
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complication (odds ratio: 0.5195; CI 95%:0.0637-4.2379; 
p=0.6), weight at the birth <1500 gr (odds ratio: 6.2796; 
CI 95%: 0.3601-109.5044; p=0.2), use of antibiotics ( 
odds ratio:3.0114; CI 95%: 0.6353-14.2732; p=0.1), use 
of ototoxic antibiotics (odds ratio: 3.9241; CI 95%: 0.6955-
15.6016; p=0.1), assisted procreation (odds ratio: 6.3182; 
CI 95%: 0.5303-752780; p=0.1), and consanguinity (odds 
ratio: 6.3196; CI 95%: 0.5398-752225; p=0.1) (Table 4).
DISCUSSION
SNHL in children is a condition that significantly affects 
speech, language and psychological development when 
in the bilateral severe and profound forms26,27, and that 
may have social consequences and auditory symptoms 
such as tinnitus and hyperacusis when unilateral or 
in the mild and moderate forms28-32. This study aimed 
to evaluate the prevalence of SNHL in newborns 
hospitalized in NICU, and the correlation of several risk 
factors with hearing loss. In our sample, the prevalence 
of SNHL observed in children hospitalized in NICU was 
7.8%; nearly 60% of them had a profound hearing loss. 
The prevalence in our sample is significantly higher 
to that reported by Coenraad et al. (1.7%)20, Hille et al. 
(3.1%)33 and Robertson et al (3.2%)24 this may be due to 
the small size of our sample. The majority of infants with 
SNHL in our population had a profound hearing loss; 
this is in accordance with Coenraad20 and Robertson24. 
Most of the children included in our study presented 
prematurity, a common reason of admission to NICU; 
this was equally present in children with SNHL and in 
normal hearing population but children with hearing loss 
had a slightly lower mean gestational age (28 weeks) 
compared to normal hearing children (31-32 weeks). 
Caesarian childbirth, twin pregnancy, sepsis and surgery 
were more common in children with a diagnosis of SNHL 
compared to normal hearing children; this data could 
be explained by the systemic hypoperfusion that may 
have an impact on the ear perfusion and contribute to 
inner cells death34; furthermore, sepsis and surgery may 
increase the circulating reactive oxygen species (ROS) 
responsible of oxidative damage in the inner ear32-36. 
In case of maternal diseases, even if treated correctly 
with therapy, the risk of developing SNHL in our sample 
was slightly increased; this may follow the alteration of 
the normal maternal homeostasis/metabolism that may 
determine both pressure variations and increasing of 
ROS able to damage the inner ear structure of children37. 
We did not observe an increased prevalence of SNHL in 
babies hospitalized in NICU over five days, that underwent 
to antibiotics treatment and that presented a low weight 
at birth. These findings are in contrast with other authors’ 
results and the JCIH, that observed with an increased risk 
of developing SNHL in these children14-38. We attribute 
this finding to the small size of our sample. Similarly, it 
was not observed a higher prevalence of hearing loss 
in children with low Apgar score, maternal infections, 
mechanical ventilation, cerebral complication, assisted 
procreation and chromosomic disorders. This may be 
correlated with the characteristic of our sample and with 
the management of newborns in our NICU. The control 
of the infections by specific treatment administered since 
the early stage of pregnancy decreased the risk of viral 
infections; while the mechanic ventilation with personal 
assistance (several control daily) avoided quick changes 
of oxygenation values that might impact on the inner ear 
structures39,40.
CONCLUSION
SNHL in newborns is correlated with hospitalization 
in NICU. The early diagnosis and intervention in 
children with hearing loss at <6 months of age leads to 
significantly better outcomes for speech and language 
development compared to non-treated children Although 
universal newborn hearing screening programs allow 
early identification of children with hearing loss, a specific 
attention should be dedicated to children hospitalized in 
NICU, in which an accurate early audiological evaluation 
associated to a rigorous clinical medical collection of data 
is always necessary due to the higher risk of SNHL.
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